| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 6 | |
| #2 | WIPO (World Intellectual Property Organization) | 2 | |
| #3 | Australia | 1 | |
| #4 | Canada | 1 | |
| #5 | EPO (European Patent Office) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Measurement | |
| #4 | Organic fine chemistry | |
| #5 | Environmental technology |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Microorganisms | |
| #4 | Climate change adaptation technologies | |
| #5 | Peptides | |
| #6 | Heterocyclic compounds | |
| #7 | Analysing materials |
| # | Name | Total Patents |
|---|---|---|
| #1 | Lori Franco | 11 |
| #2 | Lisziewicz Julianna | 5 |
| #3 | Gao Wen-Yi | 2 |
| #4 | Gallo Robert C | 2 |
| #5 | Cara Andrea | 2 |
| #6 | Solinas Antonio | 1 |
| #7 | Lisziewicz Juliana | 1 |
| #8 | Kéri György | 1 |
| #9 | Calarota Sandra A | 1 |
| #10 | De Forni Davide | 1 |
| Publication | Filing date | Title |
|---|---|---|
| US2012022048A1 | Anti-proliferative substituted pyrazolo[3,4-d]pyrimidines derivatives (SPP) to inhibit immune activation, virus replication and tumor growth | |
| US2009317466A1 | Fixed dose pharmaceutical composition comprising hyroxyurea and didanosine | |
| AU2002322013A1 | Therapeutic dna vaccination | |
| WO0045844A1 | Use of hydroxyurea and a reverse transcriptase inhibitor to induce autovaccination by autologous hiv | |
| WO9948526A1 | METHOD OF RENDERING A HUMAN IMMUNODEFICIENCY VIRUS POPULATION REPLICATION INCOMPETENT $i(IN VIVO) |